HC Wainwright Equities Analysts Reduce Earnings Estimates for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Free Report) – Stock analysts at HC Wainwright decreased their FY2027 earnings per share (EPS) estimates for shares of Calliditas Therapeutics AB (publ) in a note issued to investors on Thursday, February 22nd. HC Wainwright analyst A. He now forecasts that the company will earn $6.27 per share for […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: The Home Depot, Inc. (NYSE:HD) CEO Sells 35,987 Shares of Stock
Next post Travis Boersma Sells 404,950 Shares of Dutch Bros Inc. (NYSE:BROS) Stock